A platform built around hormone optimization that adds GLP-1s is optimized for hormone therapy first
Consistent access to therapy is also essential, as interruptions can worsen GI symptoms and reduce adherence
Only one human joint study with 12 patients
When reconstituted, it maintains structural integrity suitable for cellular and molecular research models
In addition, 7-DHC accumulation significantly reduces metabolic stress in the body (Freitas et al., 2024)
Cross-functional coordination Coordinate across clinical, commercial, product, engineering, operations, and regulatory partners to keep GLP-1 program work aligned, unblocked, and advancing